Michael A. Gleason

Jones Day (Washington DC)
Lawyer (Partner)

Michael Gleason has more than 13 years of experience and has been involved in some of the most significant transactions to recently come before the antitrust agencies, particularly in the health care industry. He counsels clients on antitrust matters before U.S. and international enforcement agencies, including M&A transactions and government investigations, as well as antitrust litigation.

Linked authors

Jones Day (Houston)
Jones Day (Washington DC)
Jones Day (Sillicon Valley)
Jones Day (Mexico)
Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (London)

Articles

253 Bulletin

Matt Evans, Michael A. Gleason, Prudence Smith, Jason Beer The UK Competition Authority proposes the creation of a new regulatory authority and additional regulations to govern the conduct of online platforms funded by digital advertising

26

INTRODUCTION The CMA has recently issued its Final Report in the Market Study into Online Platforms and Digital Advertising (“Final Report”), which sets forth its findings and recommendations from its investigation of markets involving online platforms funded by digital advertising. In parallel, (...)

Michael A. Gleason, Michael H. Knight, Lauren Miller Forbes, John Magruder The US DoJ and FTC issue guidance on merger review during the COVID-19 outbreak and confirm that they continue to operate despite merging parties expecting lengthier reviews

43

The FTC and DOJ have adopted new procedures in response to the novel coronavirus (COVID-19) pandemic. The changes are intended to help the agencies stay open during the crisis, but merging parties should expect lengthier antitrust reviews until normal operations resume. All merger filings with (...)

Send a message